It is worth noting that the concomitant inhibition of VEGF and TNF-α was previously shown to improve clinical outcomes in AMD and macular edema patients [16,17], thus confirming our observations in this study and suggesting that the concomitant inhibition of VEGF and TNF-α could be a preferred therapy for ocular burns. The gene discussed is VEGFA; the disease is macular retinal edema.